Mohammad Ganji, Shahla, Samei, Elham, Hashemi, Seyed Ahmad, Rezagholizadeh, Amir, Kazemnejad, Anooshirvan, Mostakhdemin Hosseini, Zahra (2013). Investigation of the E-cadherin Promoter Methylation in Patients with Colorectal Cancer in Iran. , 16(2), 75-83.
Shahla Mohammad Ganji; Elham Samei; Seyed Ahmad Hashemi; Amir Rezagholizadeh; Anooshirvan Kazemnejad; Zahra Mostakhdemin Hosseini. "Investigation of the E-cadherin Promoter Methylation in Patients with Colorectal Cancer in Iran". , 16, 2, 2013, 75-83.
Mohammad Ganji, Shahla, Samei, Elham, Hashemi, Seyed Ahmad, Rezagholizadeh, Amir, Kazemnejad, Anooshirvan, Mostakhdemin Hosseini, Zahra (2013). 'Investigation of the E-cadherin Promoter Methylation in Patients with Colorectal Cancer in Iran', , 16(2), pp. 75-83.
Mohammad Ganji, Shahla, Samei, Elham, Hashemi, Seyed Ahmad, Rezagholizadeh, Amir, Kazemnejad, Anooshirvan, Mostakhdemin Hosseini, Zahra Investigation of the E-cadherin Promoter Methylation in Patients with Colorectal Cancer in Iran. , 2013; 16(2): 75-83.

Investigation of the E-cadherin Promoter Methylation in Patients with Colorectal Cancer in Iran

Pathobiology Reserach
Article 7, Volume 16, Issue 2, 2013, Pages 75-83    PDF (629.86 K)
Authors
Shahla Mohammad Ganji* 1; Elham Samei1; Seyed Ahmad Hashemi1; Amir Rezagholizadeh2; Anooshirvan Kazemnejad3; Zahra Mostakhdemin Hosseini4
1Department of Molecular Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
2Department of Biology, Islamic Azad University, East Tehran branch, Tehran, Iran
3Department of Biostatistics, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
4Iran Tumor bank, Cancer Institute, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
Abstract
Objective: E-cadherin is widely down-regulated and tightly associated with tumor invasion and metastasis in multiple human cancer types. Recent studies have shown that aberrant methylation of the E-cadherin gene promoter contributes to its silencing. However, information regarding epigenetic inactivation of E-cadherin in colorectal cancer is insufficient. Herein, we correlate association of the methylation of the E-Cadherin promoter with pathological features of colorectal cancer as well as history and demographic data. Methods: We used methylation specific polymerase chain reaction (MSPCR) to examine methylation status of the 5’ CpG island of E-cadherin along with its expression by using RT-PCR following surgical resection of 66 unrelated patients with colorectal cancer. Results: Results showed that 35 out of 66 tumor DNA samples (53%) showed aberrant methylations. In contrast, all normal tissues were unmethylated. Conclusion: The obtained results show a similarity with the Japanese (54.5%) and Greek (55.7%) populations. The results have confirmed methylation of this gene in sporadic colorectal cancer cases (40.8%) in the Iranian population by researchers in Shiraz. These data suggest that epigenetic silencing via aberrant methylation of the E-cadherin promoter plays a critical role in the inactivation of this tumor suppressor gene in colorectal cancer.
Keywords
Colorectal cancer; E-cadherin promoter; Methylation; Epigenetic
References
Statistics
Article View: 142
PDF Download: 73
Statistics
Number of Journals45
Number of Issues2,196
Number of Articles24,880
Article View28,806,777
PDF Download18,606,656